This article shares the results from an evaluation of a novel thermal imaging technology that took place before the initial implementation in a Pfizer manufacturing facility. The manuscript describes the technology and reviews the extensive process used to challenge its inspection capabilities through field testing. Finally, the potential benefits of adopting this first-in-class pharmaceutical technology as a new standard for non-destructive testing1,2 of bottle induction sealing integrity in the pharmaceutical industry is summarised.
HIGH-RESOLUTION, cryogenically cooled thermal imaging technology was initially developed for military purposes. Furthering the commercialisation of the technology for civil applications, a pharmaceutical assembly – for high-speed and 100 percent inline verification of induction integrity in bottle packaging – was first developed and made available for testing relatively recently.3 This article summarises outcomes from initial plant feasibility work and extended rigorous proof-of-concept trials. The evaluation process resulted in the first Pfizer network implementation of the technology for the routine inspection of heat induction foil sealing integrity in a high‑speed bottle packaging line at a pharmaceutical manufacturing facility.
This report addresses the key factors shaping pharmaceutical formulation, including regulation, QC and analysis.
Access the full report now to discover the techniques, tools and innovations that are transforming pharmaceutical formulation, and learn how to position your organisation for long-term success.
What you’ll discover:
Key trends shaping the pharmaceutical formulation sector
Innovations leading progress in pharmaceutical formulation and how senior professionals can harness their benefits
Considerations and best practices when utilising QbD during formulation of oral solid dosage forms
Can’t attend live? No worries – register to receive the recording post-event.
Background
The need to improve sealing inspection triggered a search for technologies resulting in the development of a new application of high-resolution thermal imaging”
As part of identifying continuous improvement opportunities for packaging processes, a request was made to enlist the top unmet technical challenges at a Pfizer manufacturing facility. The intention was to identify recurring issues and evaluate potential solutions. From an initial list, the top unmet technical requirement identified – based on criticality and occurrence – was related to customer complaints due to incomplete foil sealing in bottles. This is considered a critical defect because of its potential to negatively impact product integrity, stability and efficacy during the claimed shelf-life period.
In the past, there was no technology available to enable automated 100 percent inline inspection of foil sealing integrity through the caps for bottle packaging. Once the bottle was capped, the integrity of the seal could only be verified by removing the cap. Therefore, the seal integrity attribute relied on in-process testing based on a statistical sampling of bottles. Samples were manually handled, bottle caps were individually removed and foil sealing integrity was visually checked in an off-line fashion. When sealing issues were found, the path forward usually involved either increasing the overall number of samples for off-line inspection or arranging for 100 percent manual inspection of the batch as a separate unitary process. The latter significantly increased production cycle times and required a considerable amount of additional resources to execute. In addition, the risks for human errors and ergonomic issues grew during this labour‑intensive activity. The need to improve sealing inspection triggered a search for technologies resulting in the development of a new application of high‑resolution thermal imaging.
Apparatus and principle of measurement
The high-resolution thermal imaging apparatus implemented as a result of the evaluation described in this article is named Induction Integrity Verification System (I2VS) from DIR Technologies, Haifa, Israel*. From a high-level and general standpoint, this technology leverages black body radiation principles as it captures and visualises the electromagnetic radiation emitted by an object (or focus area thereof) of interest.
Implementation of the technology eliminates the need for sampling and off-line inspection, reducing operator interventions and potential human errors during visual inspection”
Electromagnetic radiation is emitted by warm bodies due to the thermally-induced motion of molecules.4,5 In principle, thermal imaging cameras detect the radiation emitted by objects at temperatures above absolute zero. The images generated – also known as thermographs – capture information on temperature variations, as the amount of radiation emitted by an object in the infrared spectrum increases with temperature.6 In practice, the radiation emitted at these wavelengths by objects can often penetrate most plastics.
In the specific application of bottle packaging, the sensing apparatus can capture the electromagnetic radiation contour emitted by the foil sealing ring through the polymer plastic caps. This enables the generation of thermographs of the covered foil that are not possible with visible light-based imaging systems. For this inspection application, the thermal imaging camera is positioned immediately after the induction sealing step above the conveyor belt that transports the capped bottles. After capturing the radiation patterns from the induction sealed foil ring of each bottle, the information is analysed in real‑time using high-speed image processing software. Pre-determined algorithms and adjusted threshold values for thermal pattern variability allow for discrimination and detection of a range of defects that end up impacting bottle foil seal integrity.
*DIR Technologies is no longer in business, but the intellectual property associated with this application has been sold to a third party.
Field evaluation of technology
During a search for an appropriate solution, it was found that a thermal imaging technology with the potential to inspect foil sealing integrity inline was being evaluated on some external technology forums at the time. However, there was limited information about its performance in a commercial high-speed production environment. The technology seemed promising, but there was a level of risk involved due to the uncertainty of its effectiveness as well as the level of capital investment required for full implementation. Ultimately, it was agreed with the vendor to collaboratively perform plant feasibility work to understand the technology’s capabilities and applicability to our inspection needs.
Figure 1: Left: Basic high-resolution thermal imaging assembly used for initial feasibility work. Middle: Field tester unit used for extended plant proof-of-concept trials. Right: Commercial system implemented in a high-speed bottle packaging line in a Pfizer manufacturing facility.
Feasibility work (Figure 1) was performed using a prototype system consisting of a thermal imaging camera mounted on a portable tripod and a computer with software to control the capture of the thermographs and conduct their evaluation. Empty bottles were used to test the system defect detection capabilities at this early stage. The study confirmed the equipment capabilities to identify a wide range of the typical bottle sealing defects observed in a pharmaceutical packaging environment. The results obtained in the prototype phase (Figure 2) were very promising, which led to a second phase for extended plant proof‑of-concept trials.
Figure 2: Left: Initial plant feasibility work performed in collaboration between vendor company, a Pfizer manufacturing site and Pfizer’s GT&E Manufacturing Intelligence team. Right: Sample defects consistently captured by thermal imaging system during initial plant feasibility work.
The second phase of the evaluation involved the installation of a portable field tester prototype to perform extended plant proof-of-concept trials during commercial production. The unit was installed at different packaging lines (Figure 3) with aims to cover most bottle/cap sizes and combinations, different types of closures (continuous thread, squeeze and turn, etc) and varying line conveyor speeds. The plan intended to thoroughly challenge the technology capabilities in a representative production environment – involving a significant period of time – to generate enough data on system performance, stability and ruggedness.
Figure 3: Thermal imaging field tester unit previously installed at four different packaging lines across two Pfizer manufacturing facilities during extended plant proof-of-concept trials.
The focused testing activities provided factual confirmation of the system’s detection and automated ejection capabilities for sealing defects resulting from broken and folded liners, under- and over-heated seals, high/unengaged caps, inverted foil liner and no induction (Figure 4) with a high degree of accuracy. It also provided inspection redundancy for defects such as skewed caps, which traditional checkpoint sensors have previously shown to occasionally fail to detect. These capabilities were later formally documented as part of the implementation cycle of the technology, including system acceptance tests (FAT/SAT) and validation (OQ/PQ).
Figure 4: Summary of the defects consistently captured and sample thermographs from extended plant proof-of-concept trials with thermal imaging technology.
Benefits of thermal imaging technology
The implemented thermal imaging system provides numerous significant benefits. For example, implementation of the technology eliminates the need for sampling and off-line inspection, reducing operator interventions and potential human errors during visual inspection. Additionally, process improvements are realised from a data integrity perspective.
By enabling high-speed 100 percent inline inspection through the caps, the technology avoids defective products from reaching customers without increasing packaging cycle times. Improved process robustness means reducing defects and customer complaints, which cascades into cost avoidances due to fewer investigations.
At the operational level, the instant feedback provided by the technology can help to optimise the initial set-up of the capper and induction sealing machines. It can also be used to improve the set-up of dimension-based sensor assemblies at traditional checkpoints if the user decides to keep them for redundant detection capabilities. In addition, the technology can also help with early identification of the need for maintenance on these machines and/or sensor assemblies based on actual performance.
Furthermore, the thermal imaging system is capable of classifying the types of defects detected. This functionality aids during troubleshooting and can expedite root cause identification. Based on our experience, most defects are either process- or material-related. Monitoring and quantification of material-related defects can support evidence-based negotiations to request quality improvements from suppliers. Additionally, the immediate detection of recurrent defects also serves as early identification of process shifts that could be caused due to material variation or mechanical failures. Lastly, on a more strategic level, avoiding defects from reaching customers protects – and in the longer term may help improve – brand image.
Final remarks
This article shared the evaluation of a novel thermal imaging technology that resulted in the implementation of the technology at a Pfizer manufacturing facility (Figure 5). The technology’s capabilities were thoroughly challenged in a rigorous process that focused on field testing. The thermal imaging system consistently showed first-ever equipment capabilities to detect a wide range of induction sealing defects during bottle packaging with a high degree of accuracy. This manuscript also summarised some of the key benefits of this first‑in‑class pharmaceutical technology.
Figure 5: First Pfizer network implementation of Induction Integrity Verification System (I2VS) thermal imaging technology at a high‑speed bottle packaging line at a Pfizer manufacturing facility.
Bottle seal integrity has been historically tested by sampling a finite number of bottles and manually removing caps to visually inspect foil seal off-line as an in-process verification during the packaging process. Traditional technologies cannot directly inspect the quality of the sealing in an inline fashion. In the authors’ view, the capabilities of this new high-resolution thermal imaging technology provide a tangible and disruptive improvement to inspection that raises the bar for quality assurance and has the potential to become the new standard for the verification of induction sealing integrity in the pharmaceutical industry.
Acknowledgements
Many colleagues were directly and indirectly involved in supporting the activities described in this article. Since the list is too long to mention them individually, the authors prefer to collectively thank the Pfizer network of technical colleagues, as well as vendors and contractors, that collaborated to realise this work.
About the authors
José-Miguel Montenegro-Alvarado is Manager of Process Analytical Technology projects as part of Pfizer’s Global Technology & Engineering/ Manufacturing Intelligence Team. Based in Puerto Rico, in his current role he is responsible for leading the identification, evaluation and implementation of technology innovation projects to increase manufacturing efficiency at multiple Pfizer’s Small Molecule Operation (SMO) network sites in Latin America and Puerto Rico. José’s academic background includes Bachelor’s and Master’s degrees in Chemical Engineering at the University of Puerto Rico – Mayagüez with a minor equivalency in Economics. His professional career in the pharmaceutical industry started in 2001 at the Searle & Co. Caguas site after industrial internships in medical devices with Baxter and Techno-Plastics Industries. Following a series of mergers and acquisitions (Pharmacia, Pfizer), in 2007 he was recruited by Pfizer Center Functions as part of the Process Analytical Sciences Group. In this time, José has interfaced with over 20 Pfizer sites in four different continents including Argentina, Australia, Brazil, Italy, Mexico, Puerto Rico, Spain, the US and Venezuela. In 2010 he transitioned into his current role as Manager – PAT projects.
Iván Avilés- Segundo began his career in the pharmaceutical industry in 1991 for MOVA Pharmaceuticals in Puerto Rico. Since then, he has worked for Eli Lilly, Searle & Co, Pharmacia and Pfizer. Iván has over 29 years of experience in pharmaceutical packaging and equipment. In his current role as Packaging Technical Services Manager, he is responsible for the technical support to packaging lines, packaging engineering, validations, production documentation, specifications and Bill of Materials. He also leads the packaging PMO team supporting the product transfers into the site and regulatory changes to packaging products. Iván also serves as the site Packaging Serialization Business as usual point of contact (BAU POC). He holds a BSc in Industrial Engineering from the Polytechnic University of PR, an MBA from the University of Phoenix, a Master’s in Industrial and Systems Engineering from Auburn University in Alabama and a PhD in Engineering and Applied Sciences from the Polytechnic University of Puerto Rico. Iván is also a registered professional engineer.
References
Meola, C.; Boccardi, S.; Carlomagno, G.M. (2017). “Chapter 4 – Non-destructive Testing with Infrared Thermography”. Published in Infrared Thermography in the Evaluation of Aerospace Composite Materials, Woodhead Publishing (2017), pp. 85-125. Electronically retrieved on September 12, 2020 from ScienceDirect website at https://www.sciencedirect.com/science/article/pii/B9781782421719000048.
Montenegro-Alvarado, J.; Diehl, B.; Guay, J.M.; Hammond, S.; Isaac, H.; Lyons, B.; McSweeney, C.; O’Neill, S.; Simard, J.S.; Timmermans, J. (2014). “PAT for Packaging: Review of Applications for Expeditious, Non-destructive Quality Testing”. Published in European Pharmaceutical Review, 19(2), April 2014.
This website uses cookies to enable, optimise and analyse site operations, as well as to provide personalised content and allow you to connect to social media. By clicking "I agree" you consent to the use of cookies for non-essential functions and the related processing of personal data. You can adjust your cookie and associated data processing preferences at any time via our "Cookie Settings". Please view our Cookie Policy to learn more about the use of cookies on our website.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorised as ”Necessary” are stored on your browser as they are as essential for the working of basic functionalities of the website. For our other types of cookies “Advertising & Targeting”, “Analytics” and “Performance”, these help us analyse and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these different types of cookies. But opting out of some of these cookies may have an effect on your browsing experience. You can adjust the available sliders to ‘Enabled’ or ‘Disabled’, then click ‘Save and Accept’. View our Cookie Policy page.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Cookie
Description
cookielawinfo-checkbox-advertising-targeting
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertising & Targeting".
cookielawinfo-checkbox-analytics
This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".
cookielawinfo-checkbox-necessary
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance
This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Performance".
PHPSESSID
This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
zmember_logged
This session cookie is served by our membership/subscription system and controls whether you are able to see content which is only available to logged in users.
Performance cookies are includes cookies that deliver enhanced functionalities of the website, such as caching. These cookies do not store any personal information.
Cookie
Description
cf_ob_info
This cookie is set by Cloudflare content delivery network and, in conjunction with the cookie 'cf_use_ob', is used to determine whether it should continue serving “Always Online” until the cookie expires.
cf_use_ob
This cookie is set by Cloudflare content delivery network and is used to determine whether it should continue serving “Always Online” until the cookie expires.
free_subscription_only
This session cookie is served by our membership/subscription system and controls which types of content you are able to access.
ls_smartpush
This cookie is set by Litespeed Server and allows the server to store settings to help improve performance of the site.
one_signal_sdk_db
This cookie is set by OneSignal push notifications and is used for storing user preferences in connection with their notification permission status.
YSC
This cookie is set by Youtube and is used to track the views of embedded videos.
Analytics cookies collect information about your use of the content, and in combination with previously collected information, are used to measure, understand, and report on your usage of this website.
Cookie
Description
bcookie
This cookie is set by LinkedIn. The purpose of the cookie is to enable LinkedIn functionalities on the page.
GPS
This cookie is set by YouTube and registers a unique ID for tracking users based on their geographical location
lang
This cookie is set by LinkedIn and is used to store the language preferences of a user to serve up content in that stored language the next time user visit the website.
lidc
This cookie is set by LinkedIn and used for routing.
lissc
This cookie is set by LinkedIn share Buttons and ad tags.
vuid
We embed videos from our official Vimeo channel. When you press play, Vimeo will drop third party cookies to enable the video to play and to see how long a viewer has watched the video. This cookie does not track individuals.
wow.anonymousId
This cookie is set by Spotler and tracks an anonymous visitor ID.
wow.schedule
This cookie is set by Spotler and enables it to track the Load Balance Session Queue.
wow.session
This cookie is set by Spotler to track the Internet Information Services (IIS) session state.
wow.utmvalues
This cookie is set by Spotler and stores the UTM values for the session. UTM values are specific text strings that are appended to URLs that allow Communigator to track the URLs and the UTM values when they get clicked on.
_ga
This cookie is set by Google Analytics and is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. It stores information anonymously and assign a randomly generated number to identify unique visitors.
_gat
This cookies is set by Google Universal Analytics to throttle the request rate to limit the collection of data on high traffic sites.
_gid
This cookie is set by Google Analytics and is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visited in an anonymous form.
Advertising and targeting cookies help us provide our visitors with relevant ads and marketing campaigns.
Cookie
Description
advanced_ads_browser_width
This cookie is set by Advanced Ads and measures the browser width.
advanced_ads_page_impressions
This cookie is set by Advanced Ads and measures the number of previous page impressions.
advanced_ads_pro_server_info
This cookie is set by Advanced Ads and sets geo-location, user role and user capabilities. It is used by cache busting in Advanced Ads Pro when the appropriate visitor conditions are used.
advanced_ads_pro_visitor_referrer
This cookie is set by Advanced Ads and sets the referrer URL.
bscookie
This cookie is a browser ID cookie set by LinkedIn share Buttons and ad tags.
IDE
This cookie is set by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
li_sugr
This cookie is set by LinkedIn and is used for tracking.
UserMatchHistory
This cookie is set by Linkedin and is used to track visitors on multiple websites, in order to present relevant advertisement based on the visitor's preferences.
VISITOR_INFO1_LIVE
This cookie is set by YouTube. Used to track the information of the embedded YouTube videos on a website.